Streptolysin O concentration and activity is central to in vivo phenotype and disease outcome in Group A Streptococcus infection

Streptolysin O concentration and activity is central to in vivo phenotype and disease outcome in Group A Streptococcus infection

Group A Streptoccocus (GAS) is among the many most numerous of all human pathogens, accountable for a variety of medical manifestations, from delicate superficial infections akin to pharyngitis to severe invasive infections akin to necrotising fasciitis and sepsis.
The drivers of those completely different illness phenotypes aren’t recognized. The GAS cholesterol-dependent cytolysin, Streptolysin O (SLO), has properly established cell and tissue harmful exercise. We investigated the position of SLO in figuring out illness final result in vivo, by utilizing two completely different medical lineages; the not too long ago emerged hypervirulent outbreak emm kind 32.2 strains, which end in sepsis, and the emm kind 1.Zero strains which trigger septic arthritis.
Utilizing clinically related in vivo mouse fashions of sepsis and a novel septic arthritis mannequin, we discovered that the quantity and exercise of SLO was important in figuring out the course of an infection. The emm kind 32.2 pressure produced giant portions of extremely haemolytic SLO that resulted in speedy growth of sepsis.
Against this, the lowered focus and decrease haemolytic exercise of emm kind 1.Zero SLO led to translocation of micro organism from blood to joints. Importantly, sepsis related strains that have been attenuated by deletion or inhibition of SLO, then additionally translocated to the joint, confirming the important thing position of SLO in figuring out an infection area of interest.
Our findings show that SLO is vital to in vivo phenotype and illness final result. Cautious consideration needs to be given to novel remedy or vaccination methods that focus on SLO. While neutralising SLO exercise might cut back extreme invasive illness, it has the potential to advertise continual inflammatory circumstances akin to septic arthritis.

A longitudinal sampling research of transcriptomic and epigenetic profiles in sufferers with thrombocytopenia syndrome’

Extreme fever with thrombocytopenia syndrome (SFTS) is a novel tick-borne infectious illness attributable to a brand new kind of SFTS virus (SFTSV). Right here, a longitudinal sampling research is performed to discover the variations in transcript ranges after SFTSV an infection, and to characterize the transcriptomic and epigenetic profiles of hospitalized sufferers.
The outcomes reveal important modifications within the mRNA expression of sure genes from onset to restoration. Furthermore, m6A-seq reveals that sure genes associated with immune regulation could also be regulated by m6A.
Moreover the routine checks akin to platelet counts, serum ALT and AST ranges testing, distinct modifications in myocardial enzymes, coagulation perform, and irritation are properly correlated with the medical knowledge and sequencing knowledge, suggesting that medical practitioners ought to monitor the above indicators to trace illness development and information personalised therapy.
On this research, the transcript modifications and RNA modification might lend a contemporary perspective to our understanding of the SFTSV and play a major position within the discovery of medication for efficient therapy of this illness.

Optimising classification of Parkinson’s illness primarily based on motor, olfactory, neuropsychiatric and sleep options

Olfactory loss, motor impairment, anxiousness/despair, and REM-sleep behaviour dysfunction (RBD) are prodromal Parkinson’s illness (PD) options. PD threat prediction fashions sometimes dichotomize take a look at outcomes and apply probability ratios (LRs) to scores above and under cut-offs. We examine whether or not LRs for particular take a look at values might improve classification between PD and controls.
PD affected person knowledge on odor (UPSIT), attainable RBD (RBD Screening Questionnaire), and anxiousness/despair (LADS) have been taken from the Monitoring Parkinson’s research (n = 1046). For motor impairment (BRAIN take a look at) in PD circumstances, revealed knowledge have been supplemented (n = 87). Management knowledge (HADS for anxiousness/despair) have been taken from the PREDICT-PD pilot research (n = 1314).
UPSIT, RBDSQ, and anxiousness/despair knowledge have been analysed utilizing logistic regression to find out which gadgets have been related to PD. Gaussian distributions have been fitted to BRAIN take a look at scores. LRs have been calculated from logistic regression fashions or rating distributions. False-positive charges (FPRs) for specified detection charges (DRs) have been calculated.
Sixteen odours have been related to PD; LRs for this set ranged from 0.005 to 5511. Six RBDSQ and 7 anxiousness/despair questions have been related to PD; LRs ranged from 0.35 to 69 and from 0.002 to 402, respectively. BRAIN take a look at LRs ranged from 0.16 to 1311. For a 70% DR, the FPR was 2.4% for the 16 odours, 4.6% for anxiousness/despair, 16.0% for the BRAIN take a look at, and 20.0% for the RBDSQ.
Particular choices of (prodromal) PD marker options reasonably than dichotomized marker take a look at outcomes optimize PD classification. Such optimized classification fashions might enhance the power of algorithms to detect prodromal PD; nevertheless, potential research are wanted to analyze their worth for PD-prediction fashions.

Sleep issues in ache sufferers coming into tertiary ache care: the position of pain-related anxiousness, medicine use, self-reported ailments, and sleep issues

Continual ache and sleep issues regularly co-occur. Ache itself disturbs sleep, however different elements can also contribute to sleep issues in ache sufferers. This cross-sectional research of 473 sufferers (69.9% feminine, imply age 47 years) coming into tertiary ache administration in contrast usually sleeping ache sufferers with these having recurring sleep issues to find out the connection between ache and sleep.
Teams have been in contrast for ache and ache aetiology, pain-related anxiousness, childhood adversities, use of sleep and ache medicines, self-reported ailments, and sleep issues. Additional, the affiliation of pain-related anxiousness (cognitive anxiousness, escape/avoidance, worry, and physiological anxiousness) with extra disturbing sleep issues was investigated in the entire cohort.
The primary outcomes have been that these with sleep issues extra typically reported a number of well being circumstances than these sleeping usually (despair 31.6% vs 5.0%; angina pectoris 6.5% vs 0.0%; bronchial asthma 19.6% vs 1.7%; low again issues 55.1% vs 23.3%; joint illness apart from rheumatoid arthritis 32.3% vs 18.3%).
Accumulations of 5 or extra childhood adversities have been extra typically current in these with sleep issues. Stressed legs signs have been extra frequent in these with sleep issues than these sleeping usually (33.2% vs 11.7%). Sufferers having sleep issues reported extra use of sleep and ache medicines than these sleeping usually. Findings about pain-related anxiousness recommend physiological reactions as important elements for elevated sleep disturbances. These elements have to be addressed within the administration of the comorbidity of ache and sleep issues and analysis to grasp mechanisms in these is sorely wanted.

Regulation and Position of αE Integrin and Intestine Homing Integrins in Migration and Retention of Intestinal Lymphocytes throughout Inflammatory Bowel Illness

Concentrating on interactions between α4β7 integrin and endothelial adhesion molecule MAdCAM-1 to inhibit lymphocyte migration to the gastrointestinal tract is an efficient remedy in inflammatory bowel illness (IBD). Following lymphocyte entry into the mucosa, a subset of those cells expresses αEβ7 integrin, which is expressed on proinflammatory lymphocytes, to extend cell retention.
The elements governing lymphocyte migration into the intestinal mucosa and αE integrin expression in wholesome topics and IBD sufferers stay incompletely understood. We evaluated modifications in elements concerned in lymphocyte migration and differentiation inside tissues.
Each ileal and colonic tissue from lively IBD sufferers confirmed upregulation of ICAM-1, VCAM-1, and MAdCAM-1 on the gene and protein ranges in contrast with wholesome topics and/or inactive IBD sufferers. β1 and β7 integrin expression on circulating lymphocytes was comparable throughout teams.
TGF-β1 therapy induced expression of αE on each β7+ and β7 T cells, suggesting that cells coming into the mucosa independently of MAdCAM-1/α4β7 can grow to be αEβ7+ ITGAE gene polymorphisms didn’t alter protein induction following TGF-β1 stimulation.
Elevated phospho-SMAD3, which is immediately downstream of TGF-β, and elevated TGF-β-responsive gene expression have been noticed within the colonic mucosa of IBD sufferers. Lastly, in vitro stimulation experiments confirmed that baseline β7 expression had little impact on cytokine, chemokine, transcription issue, and effector molecule gene expression in αE+ and αE T cells.

ARVCF - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector

TL314639 5 µg/vial Ask for price

Arvcf ORF Vector (Rat) (pORF)

ORF063700 1.0 ug DNA
EUR 607.2

ARVCF ORF Vector (Human) (pORF)

ORF015835 1.0 ug DNA
EUR 486

Arvcf ORF Vector (Mouse) (pORF)

ORF039132 1.0 ug DNA
EUR 607.2

ARVCF Protein Vector (Rat) (pPM-C-HA)

PV254800 500 ng
EUR 1399.2

ARVCF Protein Vector (Rat) (pPB-C-His)

PV254798 500 ng
EUR 1399.2

ARVCF Protein Vector (Rat) (pPB-N-His)

PV254799 500 ng
EUR 1399.2

ARVCF Protein Vector (Rat) (pPM-C-His)

PV254801 500 ng
EUR 1399.2

ARVCF Protein Vector (Human) (pPM-C-HA)

PV063339 500 ng
EUR 973.2

ARVCF Protein Vector (Mouse) (pPM-C-HA)

PV156528 500 ng
EUR 1278

ARVCF Protein Vector (Human) (pPB-C-His)

PV063337 500 ng
EUR 973.2

ARVCF Protein Vector (Human) (pPB-N-His)

PV063338 500 ng
EUR 973.2

ARVCF Protein Vector (Human) (pPM-C-His)

PV063340 500 ng
EUR 973.2

ARVCF Protein Vector (Mouse) (pPB-C-His)

PV156526 500 ng
EUR 1278

ARVCF Protein Vector (Mouse) (pPB-N-His)

PV156527 500 ng
EUR 1278

ARVCF Protein Vector (Mouse) (pPM-C-His)

PV156529 500 ng
EUR 1278

ARVCF Protein Vector (Human) (pPB-His-MBP)

PV324102 500 ng
EUR 973.2

ARVCF Protein Vector (Human) (pPB-His-GST)

PV324103 500 ng
EUR 973.2

ARVCF Protein Vector (Human) (pPM-N-D-C-HA)

PV324104 500 ng
EUR 1216.8

ARVCF Protein Vector (Human) (pPM-N-D-C-His)

PV324105 500 ng
EUR 1216.8

ARVCF siRNA

20-abx908260
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

ARVCF siRNA

20-abx908261
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

ARVCF Antibody

E40PV468 50ul
EUR 395
Description: Available in various conjugation types.

Arvcf sgRNA CRISPR Lentivector set (Rat)

K7275001 3 x 1.0 ug
EUR 406.8

Arvcf sgRNA CRISPR Lentivector set (Mouse)

K4629501 3 x 1.0 ug
EUR 406.8

ARVCF sgRNA CRISPR Lentivector set (Human)

K0129701 3 x 1.0 ug
EUR 406.8

Arvcf - Rat shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml.

TL708611V 500 ul each Ask for price

Arvcf - Mouse shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml.

TL500142V 500 ul each Ask for price

ARVCF - Human shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml.

TL314639V 500 ul each Ask for price

ARVCF Oxidase antibody

20R-2590 100 uL
EUR 612
Description: Guinea Pig polyclonal ARVCF Oxidase antibody

Arvcf sgRNA CRISPR Lentivector (Rat) (Target 1)

K7275002 1.0 ug DNA
EUR 184.8

Arvcf sgRNA CRISPR Lentivector (Rat) (Target 2)

K7275003 1.0 ug DNA
EUR 184.8

Arvcf sgRNA CRISPR Lentivector (Rat) (Target 3)

K7275004 1.0 ug DNA
EUR 184.8

Arvcf sgRNA CRISPR Lentivector (Mouse) (Target 1)

K4629502 1.0 ug DNA
EUR 184.8

Arvcf sgRNA CRISPR Lentivector (Mouse) (Target 2)

K4629503 1.0 ug DNA
EUR 184.8

Arvcf sgRNA CRISPR Lentivector (Mouse) (Target 3)

K4629504 1.0 ug DNA
EUR 184.8

ARVCF sgRNA CRISPR Lentivector (Human) (Target 1)

K0129702 1.0 ug DNA
EUR 184.8

ARVCF sgRNA CRISPR Lentivector (Human) (Target 2)

K0129703 1.0 ug DNA
EUR 184.8

ARVCF sgRNA CRISPR Lentivector (Human) (Target 3)

K0129704 1.0 ug DNA
EUR 184.8

Mouse Arvcf ELISA KIT

ELI-49351m 96 Tests
EUR 1038

ARVCF ELISA KIT|Human

EF004632 96 Tests
EUR 826.8

Human ARVCF ELISA KIT

ELI-34376h 96 Tests
EUR 988.8

Arvcf - Rat, 4 unique 29mer shRNA constructs in retroviral untagged vector

TR708611 5 µg/vial Ask for price

Human ARVCF shRNA Plasmid

20-abx950307
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

Mouse ARVCF shRNA Plasmid

20-abx969243
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

ARVCF - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector

TR314639 5 µg/vial Ask for price

Arvcf - Mouse, 4 unique 29mer shRNA constructs in retroviral untagged vector

TR500142 5 µg/vial Ask for price

ARVCF (untagged)-Human armadillo repeat gene deleted in velocardiofacial syndrome (ARVCF)

SC315001 10 µg Ask for price

Lenti ORF clone of Arvcf (mGFP-tagged) - Mouse armadillo repeat gene deleted in velo-cardio-facial syndrome (Arvcf)

MR211321L4 10 µg Ask for price

Lenti ORF particles, ARVCF (mGFP-tagged) - Human armadillo repeat gene deleted in velocardiofacial syndrome (ARVCF), 200ul, >10^7 TU/mL

RC222598L2V 200 µl Ask for price

Lenti ORF particles, ARVCF (mGFP-tagged) - Human armadillo repeat gene deleted in velocardiofacial syndrome (ARVCF), 200ul, >10^7 TU/mL

RC222598L4V 200 µl Ask for price

ARVCF (GFP-tagged) - Human armadillo repeat gene deleted in velocardiofacial syndrome (ARVCF)

RG222598 10 µg Ask for price

Lenti ORF particles, ARVCF (Myc-DDK tagged) - Human armadillo repeat gene deleted in velocardiofacial syndrome (ARVCF), 200ul, >10^7 TU/mL

RC222598L1V 200 µl Ask for price

Lenti ORF particles, ARVCF (Myc-DDK tagged) - Human armadillo repeat gene deleted in velocardiofacial syndrome (ARVCF), 200ul, >10^7 TU/mL

RC222598L3V 200 µl Ask for price

Lenti ORF particles, Arvcf (GFP-tagged) - Mouse armadillo repeat gene deleted in velo-cardio-facial syndrome (Arvcf), 200ul, >10^7 TU/mL

MR211321L4V 200 µl Ask for price

Human ARVCF knockout cell line

ABC-KH1041 1 vial Ask for price
Description: Human ARVCF knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology.

Human ARVCF Protein Lysate 20ug

IHUARVCFPLLY20UG each
EUR 361
Description: Human ARVCF Protein Lysate 20ug

Human ARVCF knockdown cell line

ABC-KD1041 1 vial Ask for price
Description: Human ARVCF knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest.

Lenti ORF clone of Arvcf (Myc-DDK-tagged) - Mouse armadillo repeat gene deleted in velo-cardio-facial syndrome (Arvcf)

MR211321L3 10 µg Ask for price

Lenti ORF particles, Arvcf (GFP-tagged ORF) - Rat armadillo repeat gene deleted in velo-cardio-facial syndrome (Arvcf), 200ul, >10^7 TU/mL

RR207946L4V 200 µl Ask for price

ARVCF (Myc-DDK-tagged)-Human armadillo repeat gene deleted in velocardiofacial syndrome (ARVCF)

RC222598 10 µg Ask for price

Arvcf sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat)

K7275005 3 x 1.0 ug
EUR 451.2

Lenti ORF particles, Arvcf (Myc-DDK-tagged) - Mouse armadillo repeat gene deleted in velo-cardio-facial syndrome (Arvcf), 200ul, >10^7 TU/mL

MR211321L3V 200 µl Ask for price

Lenti ORF clone of Arvcf (mGFP-tagged ORF) - Rat armadillo repeat gene deleted in velo-cardio-facial syndrome (Arvcf), (10 ug)

RR207946L4 10 µg Ask for price

Arvcf sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse)

K4629505 3 x 1.0 ug
EUR 451.2

ARVCF sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)

K0129705 3 x 1.0 ug
EUR 451.2

Arvcf (untagged) - Mouse armadillo repeat gene deleted in velo-cardio-facial syndrome (Arvcf), (10ug)

MC222862 10 µg Ask for price

Arvcf (GFP-tagged) - Mouse armadillo repeat gene deleted in velo-cardio-facial syndrome (Arvcf)

MG211321 10 µg Ask for price

Lenti ORF particles, Arvcf (Myc-DDK-tagged ORF) - Rat armadillo repeat gene deleted in velo-cardio-facial syndrome (Arvcf), 200ul, >10^7 TU/mL

RR207946L3V 200 µl Ask for price

Lenti ORF clone of Arvcf (Myc-DDK-tagged ORF) - Rat armadillo repeat gene deleted in velo-cardio-facial syndrome (Arvcf), (10 ug)

RR207946L3 10 µg Ask for price

OCOA14489-20UG - ARVCF Protein Lysate

OCOA14489-20UG 20ug
EUR 269

Arvcf (Myc-DDK-tagged) - Mouse armadillo repeat gene deleted in velo-cardio-facial syndrome (Arvcf)

MR211321 10 µg Ask for price

Arvcf sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1)

K7275006 1.0 ug DNA
EUR 200.4

Arvcf sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2)

K7275007 1.0 ug DNA
EUR 200.4

Arvcf sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3)

K7275008 1.0 ug DNA
EUR 200.4

Arvcf (untagged ORF) - Rat armadillo repeat gene deleted in velo-cardio-facial syndrome (Arvcf), (10 ug)

RN207946 10 µg Ask for price

Arvcf 3'UTR GFP Stable Cell Line

TU152177 1.0 ml Ask for price

ARVCF 3'UTR GFP Stable Cell Line

TU051212 1.0 ml
EUR 1672.8

Arvcf 3'UTR GFP Stable Cell Line

TU250947 1.0 ml Ask for price

Arvcf sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1)

K4629506 1.0 ug DNA
EUR 200.4

Arvcf sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2)

K4629507 1.0 ug DNA
EUR 200.4

Arvcf sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3)

K4629508 1.0 ug DNA
EUR 200.4

ARVCF sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)

K0129706 1.0 ug DNA
EUR 200.4

ARVCF sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)

K0129707 1.0 ug DNA
EUR 200.4

ARVCF sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)

K0129708 1.0 ug DNA
EUR 200.4

ARVCF guinea pig polyclonal antibody, Serum

AP09534SU-N 100 µl Ask for price

Arvcf (untagged) - Mouse armadillo repeat gene deleted in velo-cardio-facial syndrome (Arvcf), transcript variant 6

MC229118 10 µg Ask for price

Arvcf (untagged) - Mouse armadillo repeat gene deleted in velo-cardio-facial syndrome (Arvcf), transcript variant 5

MC229136 10 µg Ask for price

Arvcf (untagged) - Mouse armadillo repeat gene deleted in velo-cardio-facial syndrome (Arvcf), transcript variant 3

MC229218 10 µg Ask for price

Arvcf (untagged) - Mouse armadillo repeat gene deleted in velo-cardio-facial syndrome (Arvcf), transcript variant 4

MC229219 10 µg Ask for price

Arvcf (untagged) - Mouse armadillo repeat gene deleted in velo-cardio-facial syndrome (Arvcf), transcript variant 2

MC229223 10 µg Ask for price

AAP84952-100UG - ARVCF Peptide - middle region

AAP84952-100UG 100ug
EUR 99

ARVCF 3'UTR Luciferase Stable Cell Line

TU001212 1.0 ml
EUR 1672.8

Arvcf 3'UTR Luciferase Stable Cell Line

TU102177 1.0 ml Ask for price

Arvcf 3'UTR Luciferase Stable Cell Line

TU200947 1.0 ml Ask for price

Arvcf (Myc-DDK-tagged ORF) - Rat armadillo repeat gene deleted in velo-cardio-facial syndrome (Arvcf), (10 ug)

RR207946 10 µg Ask for price

ARP84952_P050-25UL - ARVCF Antibody - middle region

ARP84952_P050-25UL 25ul
EUR 99

ARP84952_P050 - ARVCF Antibody - middle region (ARP84952_P050)

ARP84952_P050 100ul
EUR 389

Monoclonal ARVCF Antibody (clone 5D2), Clone: 5D2

APR15077G 0.05mg
EUR 633.6
Description: A Monoclonal antibody against Human ARVCF (clone 5D2). The antibodies are raised in Mouse and are from clone 5D2. This antibody is applicable in WB and IHC-P

Arvcf (myc-DDK-tagged) - Mouse armadillo repeat gene deleted in velo-cardio-facial syndrome (Arvcf), transcript variant 6

MR231329 10 µg Ask for price

Arvcf (myc-DDK-tagged) - Mouse armadillo repeat gene deleted in velo-cardio-facial syndrome (Arvcf), transcript variant 5

MR231347 10 µg Ask for price

Arvcf (myc-DDK-tagged) - Mouse armadillo repeat gene deleted in velo-cardio-facial syndrome (Arvcf), transcript variant 3

MR231429 10 µg Ask for price

Arvcf (myc-DDK-tagged) - Mouse armadillo repeat gene deleted in velo-cardio-facial syndrome (Arvcf), transcript variant 4

MR231430 10 µg Ask for price

Arvcf (myc-DDK-tagged) - Mouse armadillo repeat gene deleted in velo-cardio-facial syndrome (Arvcf), transcript variant 2

MR231434 10 µg Ask for price

Monoclonal ARVCF Antibody (monoclonal) (M01), Clone: 5D2

APR15063G 0.1mg
EUR 580.8
Description: A Monoclonal antibody against Human ARVCF (monoclonal) (M01). The antibodies are raised in mouse and are from clone 5D2. This antibody is applicable in WB and IHC

AAP60196-100UG - ARVCF Peptide - C-terminal region

AAP60196-100UG 100ug
EUR 99

ARVCF mouse monoclonal antibody, clone 5D2, Purified

AM20470PU-N 50 µg Ask for price

ARP60196_P050-25UL - ARVCF Antibody - C-terminal region

ARP60196_P050-25UL 25ul
EUR 99

ARP60196_P050 - ARVCF Antibody - C-terminal region (ARP60196_P050)

ARP60196_P050 100ul
EUR 389

Arvcf (Rat) - 3 unique 27mer siRNA duplexes - 2 nmol each

SR507660 2 nmol Ask for price

ARVCF (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each

SR300309 2 nmol Ask for price

Arvcf (Mouse) - 3 unique 27mer siRNA duplexes - 2 nmol each

SR421458 2 nmol Ask for price

ARVD1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV719087 1.0 ug DNA Ask for price

ARVD1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV719091 1.0 ug DNA Ask for price

ARVD3 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV719093 1.0 ug DNA Ask for price

ARVD3 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV719097 1.0 ug DNA Ask for price

ARVD4 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV719099 1.0 ug DNA Ask for price

ARVD4 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV719103 1.0 ug DNA Ask for price

ARVD5 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV719105 1.0 ug DNA Ask for price

ARVD5 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV719109 1.0 ug DNA Ask for price

ARVD1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV719092 1.0 ug DNA Ask for price

ARVD3 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV719098 1.0 ug DNA Ask for price

ARVD4 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV719104 1.0 ug DNA Ask for price

ARVD5 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV719110 1.0 ug DNA Ask for price

Arvcf ELISA Kit| Mouse Armadillo repeat protein deleted in velo

EF014236 96 Tests
EUR 826.8

Arv1 - Rat, 4 unique 29mer shRNA constructs in lentiviral GFP vector

TL704784 5 µg/vial Ask for price

Arv1 - Mouse, 4 unique 29mer shRNA constructs in lentiviral GFP vector

TL504228 5 µg/vial Ask for price

ARV1 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector

TL306559 5 µg/vial Ask for price

CD Lentiviral Vector

LV678 10 μg
EUR 950

ARVD1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-C-term-HA)

LV719088 1.0 ug DNA Ask for price

ARVD3 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-C-term-HA)

LV719094 1.0 ug DNA Ask for price

ARVD4 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-C-term-HA)

LV719100 1.0 ug DNA Ask for price

ARVD5 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-C-term-HA)

LV719106 1.0 ug DNA Ask for price

Lenti ORF clone of Human armadillo repeat gene deleted in velocardiofacial syndrome (ARVCF), mGFP tagged

RC222598L2 10 µg Ask for price

Lenti ORF clone of Human armadillo repeat gene deleted in velocardiofacial syndrome (ARVCF), mGFP tagged

RC222598L4 10 µg Ask for price

ARVD1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)

LV719089 1.0 ug DNA Ask for price

ARVD1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)

LV719090 1.0 ug DNA Ask for price

ARVD3 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)

LV719095 1.0 ug DNA Ask for price

ARVD3 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)

LV719096 1.0 ug DNA Ask for price

ARVD4 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)

LV719101 1.0 ug DNA Ask for price

ARVD4 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)

LV719102 1.0 ug DNA Ask for price

ARVD5 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)

LV719107 1.0 ug DNA Ask for price

ARVD5 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)

LV719108 1.0 ug DNA Ask for price

Mouse Armadillo Repeat Gene Deleted In Velocardiofacial Syndrome (ARVCF) ELISA Kit

abx388611-96tests 96 tests
EUR 1093.2

Human Armadillo Repeat Gene Deleted In Velocardiofacial Syndrome (ARVCF) ELISA Kit

abx384600-96tests 96 tests
EUR 1093.2

Lenti ORF clone of Human armadillo repeat gene deleted in velocardiofacial syndrome (ARVCF), Myc-DDK-tagged

RC222598L1 10 µg Ask for price

Lenti ORF clone of Human armadillo repeat gene deleted in velocardiofacial syndrome (ARVCF), Myc-DDK-tagged

RC222598L3 10 µg Ask for price

Cas9 Nickase Lentiviral Vector

K005 10 ug
EUR 184.8

dCas9-KRAB Lentiviral Vector

K203 10 ug
EUR 273.6

Cas9 Nuclease Lentiviral Vector

K002 10 ug
EUR 184.8

ARVP6125 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector

TL315355 5 µg/vial Ask for price

dCas9-DNMT3A Lentiviral Vector

K091 10 µg, Titer: N/A
EUR 395
Description: N/A

dCas9-TET1CD Lentiviral Vector

K096 10 µg, Titer: N/A
EUR 395
Description: N/A

Dog Armadillo repeat protein deleted in velo cardio facial syndrome(ARVCF) ELISA kit

E08A1693-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Canine Armadillo repeat protein deleted in velo cardio facial syndrome(ARVCF) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Dog Armadillo repeat protein deleted in velo cardio facial syndrome(ARVCF) ELISA kit

E08A1693-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Canine Armadillo repeat protein deleted in velo cardio facial syndrome(ARVCF) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Dog Armadillo repeat protein deleted in velo cardio facial syndrome(ARVCF) ELISA kit

E08A1693-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Canine Armadillo repeat protein deleted in velo cardio facial syndrome(ARVCF) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rat Armadillo repeat protein deleted in velo cardio facial syndrome(ARVCF) ELISA kit

E02A1693-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Rat Armadillo repeat protein deleted in velo cardio facial syndrome(ARVCF) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rat Armadillo repeat protein deleted in velo cardio facial syndrome(ARVCF) ELISA kit

E02A1693-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Rat Armadillo repeat protein deleted in velo cardio facial syndrome(ARVCF) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rat Armadillo repeat protein deleted in velo cardio facial syndrome(ARVCF) ELISA kit

E02A1693-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Rat Armadillo repeat protein deleted in velo cardio facial syndrome(ARVCF) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig Armadillo repeat protein deleted in velo cardio facial syndrome(ARVCF) ELISA kit

E07A1693-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Porcine Armadillo repeat protein deleted in velo cardio facial syndrome(ARVCF) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig Armadillo repeat protein deleted in velo cardio facial syndrome(ARVCF) ELISA kit

E07A1693-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Porcine Armadillo repeat protein deleted in velo cardio facial syndrome(ARVCF) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig Armadillo repeat protein deleted in velo cardio facial syndrome(ARVCF) ELISA kit

E07A1693-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Porcine Armadillo repeat protein deleted in velo cardio facial syndrome(ARVCF) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rat Armadillo repeat protein deleted in velo cardio facial syndrome(ARVCF) ELISA kit

E01A9842 96T
EUR 700
Description: ELISA

Goat Armadillo repeat protein deleted in velo cardio facial syndrome(ARVCF) ELISA kit

E06A1693-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Goat Armadillo repeat protein deleted in velo cardio facial syndrome(ARVCF) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Goat Armadillo repeat protein deleted in velo cardio facial syndrome(ARVCF) ELISA kit

E06A1693-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Goat Armadillo repeat protein deleted in velo cardio facial syndrome(ARVCF) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Goat Armadillo repeat protein deleted in velo cardio facial syndrome(ARVCF) ELISA kit

E06A1693-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Goat Armadillo repeat protein deleted in velo cardio facial syndrome(ARVCF) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human Armadillo repeat protein deleted in velo cardio facial syndrome(ARVCF) ELISA kit

E01A1693-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Human Armadillo repeat protein deleted in velo cardio facial syndrome(ARVCF) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human Armadillo repeat protein deleted in velo cardio facial syndrome(ARVCF) ELISA kit

E01A1693-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Human Armadillo repeat protein deleted in velo cardio facial syndrome(ARVCF) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human Armadillo repeat protein deleted in velo cardio facial syndrome(ARVCF) ELISA kit

E01A1693-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Human Armadillo repeat protein deleted in velo cardio facial syndrome(ARVCF) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Mouse Armadillo repeat protein deleted in velo cardio facial syndrome(ARVCF) ELISA kit

E03A1693-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Mouse Armadillo repeat protein deleted in velo cardio facial syndrome(ARVCF) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Mouse Armadillo repeat protein deleted in velo cardio facial syndrome(ARVCF) ELISA kit

E03A1693-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Mouse Armadillo repeat protein deleted in velo cardio facial syndrome(ARVCF) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Mouse Armadillo repeat protein deleted in velo cardio facial syndrome(ARVCF) ELISA kit

E03A1693-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Mouse Armadillo repeat protein deleted in velo cardio facial syndrome(ARVCF) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human Armadillo repeat protein deleted in velo cardio facial syndrome(ARVCF) ELISA kit

E01A1079 96T
EUR 700
Description: ELISA

Mouse Armadillo repeat protein deleted in velo cardio facial syndrome(ARVCF) ELISA kit

E01A18584 96T
EUR 700
Description: ELISA

Goat Armadillo repeat protein deleted in velo cardio facial syndrome(ARVCF) ELISA kit

E01A44761 96T
EUR 700
Description: ELISA

Sheep Armadillo repeat protein deleted in velo cardio facial syndrome(ARVCF) ELISA kit

E01A97054 96T
EUR 700
Description: ELISA

Rabbit Armadillo repeat protein deleted in velo cardio facial syndrome(ARVCF) ELISA kit

E04A1693-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Rabbit Armadillo repeat protein deleted in velo cardio facial syndrome(ARVCF) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
These findings recommend cell migration to the intestine mucosa could also be altered in IBD and α4β7, and α4β7+ T cells might upregulate αEβ7 in response to TGF-β as soon as throughout the intestine mucosa.

Leave a Reply

Your email address will not be published. Required fields are marked *